A recent study found that women have a 21% lower risk of death compared to men, but a 12% higher risk of severe side effects from cancer treatment. The research, conducted in partnership with international collaborators, analyzed data from over 20,000 cancer patients and identified sex-based differences in survival and treatment toxicity.
SourceAdelaide University·JournalJNCI Journal of the National Cancer Institute·TypeMeta-analysis·DateMar 15, 2026
Researchers have discovered that vitamin B2 protects cancer cells from ferroptosis, a type of programmed cell death. By targeting vitamin B2 metabolism, cancer cells may become more susceptible to ferroptosis, paving the way for new cancer therapies.
SourceUniversity of Würzburg·JournalNature Cell Biology·TypeExperimental study·DateMar 13, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers at UCSF have discovered a new therapeutic target, SRC, present on up to half of all tumors, which can be targeted with antibody drugs. The enzyme, normally hidden inside cells, is exposed on the surface of tumor cells due to an overactive disposal system, making it an easy target for cancer-killing antibodies.
SourceUniversity of California - San Francisco·JournalScience·DateMar 12, 2026
The Alliance for Clinical Trials in Oncology is spotlighting new trials for colorectal cancer in March, focusing on early detection methods and treatments for treatment delays and loss of appetite. The trials aim to improve patient outcomes, with several enrolling patients with newly diagnosed colon or rectal cancer.
SourceAlliance for Clinical Trials in Oncology·DateMar 8, 2026
A new study demonstrates that blocking a signaling protein called FAK helps mobilize an anti-tumor immune response, allowing tumor-fighting cells to approach tumors and shift the behavior of other immune cells to work against them. This approach achieved the best effects on immune cell recruitment, tumor size reduction, and survival ti...
SourceSanford Burnham Prebys·JournalCell Reports·TypeExperimental study·DateMar 5, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Cancer cell-derived small extracellular vesicles can be excreted into urine, according to researchers who tracked their journey in mouse models. The study reveals that glomerular cells actively transport sEVs across the filtration barrier, supporting their use in emerging urine-based cancer diagnostics.
SourceInstitute of Science Tokyo·JournalScience Advances·TypeExperimental study·DateMar 4, 2026
The study discovered that restoring cellular vibration decreases cancer growth and severity in laryngeal cancer. Researchers exposed cancer cells to sound-wave vibration, leading to a decrease in a protein promoting cancer growth.
SourceUniversity of Turku·JournalNature Materials·DateMar 4, 2026
Researchers developed an AI-based liquid biopsy test that detects early liver fibrosis and cirrhosis, and reveals signals of broader chronic disease burden. The test uses genome-wide cell-free DNA fragmentation patterns and repeat landscapes to identify disease-specific signatures.
SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMar 4, 2026
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Researchers at Ohio University discovered that blocking the growth hormone receptor may help make lung cancer treatments more effective. Patients with low GHR tumors survived significantly longer than those with high GHR tumors, highlighting a potential new target for therapy.
SourceOhio University·JournalInternational Journal of Molecular Sciences·TypeData/statistical analysis·DateMar 2, 2026
Scientists developed a new platform using protein-like polymers to target and degrade cancer-driving proteins like MYC and KRAS. The approach triggers cancer cell death, offering hope for treating aggressive and drug-resistant cancers.
SourceNorthwestern University·JournalNature Communications·TypeExperimental study·DateFeb 24, 2026
A new study suggests that switching to a second treatment while a tumor is still responding to the first may improve cure rates. The 'kick it while it's down' approach targets small tumors and has been shown to be successful in other contexts, such as combatting antibiotic resistance.
SourceCity St George’s, University of London·JournalGenetics·TypeComputational simulation/modeling·DateFeb 20, 2026
Ovarian cancer cells recruit protective mesothelial cells in abdominal fluid to form hybrid cell clusters that resist chemotherapy. These clusters use spike-like structures called invadopodia to invade surrounding tissue. The discovery opens new treatment possibilities and could help doctors monitor disease progression.
SourceNagoya University·JournalScience Advances·TypeExperimental study·DateFeb 6, 2026
A new study suggests blocking key protein p300 can create novel form of cellular stress in cancer cells, re-sensitizing chemo-resistant tumors. Cells produce proteins even with damaged DNA, leading to toxic buildup and stress inside the cell's internal quality-control system.
SourceUniversity of Miami Miller School of Medicine·JournalGenes & Development·DateFeb 5, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Researchers at the University of Virginia Health System have identified a molecule that blocks the gene responsible for glioblastoma, a fast-growing and deadly brain cancer. The compound shows promise in preventing the invasive cancer from spreading through the brain without causing harm to healthy tissue.
SourceUniversity of Virginia Health System·DateFeb 4, 2026
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The 4-1BB-containing CAR design emerged as superior, demonstrating strongest anti-tumor activity and persistence.
SourceUniversity of California - Los Angeles Health Sciences·JournalBlood Immunology & Cellular Therapy·DateFeb 4, 2026
A national clinical trial found that oxybutynin significantly reduced hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer. The study showed substantial improvements in hot flash symptoms, often within the first week of treatment.
SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeExperimental study·DateFeb 2, 2026
Researchers developed an AI tool called ONCO-ACS to predict the risk of secondary heart attacks in cancer patients after a heart attack. The tool combines cancer-related factors with standard clinical data to provide reliable information for doctors to balance treatment benefits and harms.
SourceUniversity of Leicester·JournalThe Lancet·TypeComputational simulation/modeling·DateJan 30, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers identify a protein, PAF15, as a natural brake that prevents DNA replication from becoming overloaded and protects cells from the replication catastrophe. In cancer cells, high levels of PAF15 may create a vulnerability for targeting rapidly dividing tumor cells.
SourceUniversity of Southern Denmark·JournalNature·TypeExperimental study·DateJan 28, 2026
Researchers identified a targetable driver of brain metastases in inflammatory breast cancer, promoting tumor invasion and triggering brain inflammation via the CXCR2 signaling pathway. Targeting sEcad or the CXCR2 pathway may treat or prevent brain metastasis.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNeuro-Oncology·DateJan 28, 2026
Researchers developed miniature 3D tumor organoid models that closely mimic the human brain, revealing how glioblastoma interacts with surrounding brain cells and immune system. The models identified PTPRZ1 as a key regulator of tumor behavior, which helps determine its aggressiveness.
SourceUniversity of California - Los Angeles Health Sciences·JournalCell Reports·DateJan 27, 2026
Researchers identify acetylation as a fine cellular regulatory mechanism that affects pyruvate kinase function and stability. The study reveals isoform-specific regulation of PKM by acetylation, which helps understand how cancer cells proliferate.
SourceUniversity of Seville·JournalProceedings of the National Academy of Sciences·DateJan 23, 2026
Garmin GPSMAP 67i with inReach
Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.
Cancer researchers have identified a key mechanism by which cancer cells protect themselves from the immune system. The study found that MYC protein can bind to RNA molecules, eliminating alarm signals that would activate the immune defense.
SourceUniversity of Würzburg·JournalCell·TypeExperimental study·DateJan 22, 2026
Researchers found that cancer's powerful genetic on switches, called super-enhancers, drive intense gene activity, causing DNA breaks and stress. This can lead to accumulation of mutations over time, fueling cancer's evolution.
SourceThe Hebrew University of Jerusalem·JournalScience Advances·TypeExperimental study·DateJan 21, 2026
Georgetown University researchers discovered a method to enhance the function of T cells, making them more effective in killing cancer cells. By inhibiting PARP, an enzyme that detects DNA abnormalities, scientists can boost the body's immune response against tumors.
SourceGeorgetown University Medical Center·JournalNature Immunology·TypeExperimental study·DateJan 12, 2026
Researchers combined Dynamic Optical Contrast Imaging (DOCI) with machine learning to identify thyroid cancer during surgery. The AI analysis framework accurately classified samples across three categories and generated tumor probability maps for precise location identification.
SourceSPIE--International Society for Optics and Photonics·JournalBiophotonics Discovery·TypeObservational study·DateJan 6, 2026
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Two studies found that elevated bacteria levels in tumors weaken immune response, driving resistance to immunotherapy. Researchers are now exploring how to identify patients most likely to benefit from immunotherapy and develop targeted interventions to restore its effectiveness.
SourceCleveland Clinic·JournalNature Cancer·DateJan 2, 2026
A new study from Texas A&M University reveals that circadian disruptions change the structure of mammary glands, weaken immune defenses, and fuel aggressive breast cancer. Disabling an immune checkpoint molecule called LILRB4 helps restore the immune system's ability to fight back.
Researchers at Kyoto University identified five molecular subtypes of colorectal cancer stem cells and developed a practical prognostic indicator, the general colorectal cancer signature (GCS), to predict patient outcomes. The GCS was validated with a novel orthotopic xenograft mouse model and showed promising clinical significance.
SourceKyoto University·JournalCancer Science·TypeObservational study·DateDec 18, 2025
Researchers from A*STAR Institute of Molecular and Cell Biology discovered that Aquaporin-5 (AQP5) reliably marks gastric cancer stem cells, which drive tumour growth, spread, and recurrence. Eliminating these cells prevents tumours from growing, even in advanced disease with organ metastasis.
SourceAgency for Science, Technology and Research (A*STAR), Singapore·JournalScience·DateDec 18, 2025
A team at Penn State has developed a novel approach to treating bladder cancer using bacterial mixtures, known as microbial product cocktail immunotherapy. This method uses AI to personalize the treatment for each patient and has shown promising results in mice with bladder cancer, more than doubling long-term cancer survival rates.
SourcePenn State·JournalNature Communications·TypeExperimental study·DateDec 16, 2025
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Dr Aldona Mzyk's project uses quantum sensors to track how immune cells interact with tumours, enabling the development of improved patient-tailored cancer therapies and earlier diagnosis tools. The research aims to overcome current cancer immunotherapies' failure in solid tumours by controlling metabolic changes.
A global study found that patients with mature nodal T-cell lymphoma who relapsed within 12 months of initial treatment had worse survival outcomes, but improved survival when treated with targeted therapies instead of chemotherapy. The results suggest the need for personalized treatment strategies for high-risk patients.
SourceMass General Brigham·JournalBlood·TypeObservational study·DateDec 12, 2025
Researchers from Okayama University and Tohoku University have identified a promising way to breach the physical and biochemical barrier created by fibrosis in pancreatic cancer. By blocking collagen signaling through DDR1, they improve drug delivery and enhance treatment response.
SourceOkayama University·JournalSmall·TypeExperimental study·DateDec 11, 2025
Researchers at OIST have discovered that certain cancers can 'lose their sense of time' to avoid cellular stress responses. The study highlights the role of USP28 in stabilizing p53, a known tumor suppressor, and how mutations in this protein can disrupt its function.
SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalNature Communications·TypeImaging analysis·DateDec 9, 2025
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers mapped NBCn1's structure-function properties to understand how breast cancer cells thrive in hostile environments. The study provides insights into the protein's dynamics and ion transport pathways, paving the way for designing drugs that target this transporter.
SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·DateDec 5, 2025
A specific protein, RASH3D19, activates the RAS signaling pathway involved in aggressive tumor growth and resistance to KRAS inhibitors. Blocking RASH3D19 improves outcomes in preclinical models, suggesting a potential therapeutic strategy.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Cell Biology·DateDec 3, 2025
Researchers discovered that certain cancers rely on an emergency DNA repair mechanism called break-induced replication to survive. By understanding how this mechanism works, scientists can develop targeted therapies to selectively kill cancer cells while leaving normal cells intact.
Researchers developed a new approach using the microbial protein Archaerhodopsin-3 to induce apoptosis in cancer cells, leading to significant tumor shrinkage when exposed to green light. The findings, published by Okayama University, show great potential for this light-activated molecule as a novel cancer therapy.
SourceOkayama University·JournalJournal of the American Chemical Society·TypeExperimental study·DateDec 2, 2025
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers discovered that synthetic stress hormone dexamethasone can combat therapy-resistant breast cancer metastases in mice trials. The drug activates the glucocorticoid receptor, suppressing estrogen receptor production and slowing tumor growth. Further studies are needed to confirm these findings in patients with breast cancer.
SourceUniversity of Basel·JournalEMBO Molecular Medicine·DateNov 24, 2025
Weill Cornell Medicine researchers have discovered a molecular signal that tumors exploit to exhaust T cells meant to destroy them. By silencing this signal, the body's immunity can be revived and cancer-fighting immune cells restored.
SourceWeill Cornell Medicine·JournalNature Immunology·DateNov 17, 2025
Researchers have shown that disabling the NRF2 gene with CRISPR technology can restore drug sensitivity and slow tumor growth in lung cancer. The approach, which targets a master switch for resistance, has potential across multiple tumor types.
SourceChristianaCare Gene Editing Institute·JournalMolecular Therapy Oncology·TypeExperimental study·DateNov 17, 2025
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
A new computational tool called DeepTarget predicts direct and indirect targets of cancer drugs, revealing that small molecules can have different targets and effects depending on the disease and cell type. The study demonstrates the tool's superior performance in real-world scenarios, highlighting its potential to accelerate drug deve...
SourceSanford Burnham Prebys·Journalnpj Precision Oncology·TypeComputational simulation/modeling·DateNov 14, 2025
Researchers found that apalutamide and finasteride effectively suppressed AML progression in mice and patient-derived cells by inhibiting the androgen hormone pathway. The study provides a novel targetable pathway for leukemia patients, offering a promising new direction for treatment.
SourcePenn State·JournalBlood Advances·TypeExperimental study·DateNov 14, 2025
Researchers discovered that pancreatic tumors form pseudosynapses, exploiting the body's nervous system to drive tumor growth. Calcium waves triggered by glutamate binding promote metastasis and cancer progression.
SourceTechnical University of Munich (TUM)·JournalCancer Cell·TypeExperimental study·DateNov 11, 2025
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
Researchers discovered a new subtype of DLBCL, 'Mann-type DLBCL', which is characterized by the presence of a specific sugar called mannose. This sugar promotes the survival and growth of cancer cells, making them resistant to conventional treatments.
SourceUniversity of Southampton·JournalBlood·TypeData/statistical analysis·DateNov 11, 2025
Researchers have discovered how key molecules coordinate chromosome alignment in cell division. Dual inhibition of KIF18A and CENP-E selectively kills cancer cells, suggesting a new therapeutic avenue for cancer treatment. This study highlights the importance of targeting specific proteins to develop more effective anticancer therapies.
SourceThe University of Osaka·JournalCell Reports·TypeExperimental study·DateNov 10, 2025
Researchers at Arizona State University discovered that SerpinB3 plays a natural role in the body's wound-healing process, helping skin recover after damage. The protein helps activate keratinocytes to rebuild tissue and improve skin strength.
SourceArizona State University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 7, 2025
Researchers at University of Miami Miller School of Medicine have developed a new combination therapy that shrinks tumors, reduces cancer stem cells and reprograms immune environment to combat hormone-resistant breast cancer. The triple therapy approach targets tumor-associated macrophages, which act like bodyguards for cancer cells.
SourceUniversity of Miami Miller School of Medicine·JournalScience Translational Medicine·DateNov 5, 2025
Researchers have discovered a new way to understand cancer and its vulnerabilities by targeting FSP1, a protein that helps cancer cells survive. The study found that FSP1 inhibitors can effectively reduce the growth of metastatic melanoma cells in lymph nodes.
SourceHarvard T.H. Chan School of Public Health·JournalNature·TypeExperimental study·DateNov 5, 2025
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Scientists at Wake Forest University School of Medicine have discovered a new way to kill cancer cells by blocking their ability to clean up harmful waste. By inhibiting peroxiredoxin-3, researchers found that toxic levels of hydrogen peroxide overwhelm cancer cells, destroying them.
SourceAtrium Health Wake Forest Baptist·JournalScience Advances·DateNov 4, 2025
Researchers at Mass General Brigham have developed a strategy to promote antitumor immunity by inducing cancer cells to produce an immune-activating molecule. This approach was shown to reduce tumor growth and improve survival in mouse models of aggressive melanoma, with potential applications beyond cancer therapies.
SourceMass General Brigham·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 3, 2025
A University of Delaware student's unexpected rise as a researcher led to critical new insights into human papillomavirus (HPV) and its role in cancer. The study found that specific mutations in HPV proteins may increase cancer risk, paving the way for improved approaches to diagnosing and treating HPV-related cancers.
SourceUniversity of Delaware·JournalVirology Journal·DateOct 31, 2025
A new study led by Johns Hopkins Medicine has shown that targeted radiation during surgery can reduce pancreatic cancer recurrence rates to 5%. By targeting the 'Baltimore triangle' near the pancreas, researchers were able to eliminate cancer cells and prevent recurrences.
SourceJohns Hopkins Medicine·JournalInternational Journal of Radiation Oncology*Biology*Physics·DateOct 28, 2025
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers found that tumor-associated macrophages produce acetate through a metabolic interaction involving lactate and the lipid peroxidation–ALDH2 pathway. This acetate promotes histone H3 acetylation and epithelial-mesenchymal transition in hepatocellular carcinoma cells, enhancing metastasis.
SourceChinese Academy of Sciences Headquarters·JournalNature Metabolism·TypeExperimental study·DateOct 21, 2025
Researchers at HUN-REN Szegedi Biológiai Kutatóközpont have developed an AI-powered platform for automated 3D cell culture analysis, enabling high-precision screening of cellular models. The technology removes the limitation of throughput in personalized medicine, allowing for fast and accurate analysis of clinical samples.
SourceHUN-REN Szegedi Biológiai Kutatóközpont·JournalNature Communications·DateOct 21, 2025
A new study by Texas A&M University Health Science Center reveals how TFE3 oncofusions hijack RNA to build liquid-like hubs that promote cancer growth. The researchers also created a molecular switch to dissolve these hubs, cutting off tumor growth at its source.
SourceTexas A&M University·JournalNature Communications·DateOct 20, 2025
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
Scientists at UCL have engineered γδT cells to kill slow-growing bowel cancer cells resistant to chemotherapy. The supercharged cells outperformed regular cells, surviving longer and killing cancer cells even when they couldn't be targeted by chemotherapy.
SourceUniversity College London·JournalCancer Research·TypeExperimental study·DateOct 17, 2025
The research team developed a unique alginate-collagen interpenetrating network (IPN) hydrogel system that mimics the mechanical properties of tissues. Fibroblasts cultured on the hydrogels exhibited unprecedented behavioral patterns, including cell aggregation and reprogramming-related gene expression upregulation. The positive feedba...
SourceResearch·JournalResearch·TypeNews article·DateOct 15, 2025
Researchers at UT Austin have developed a new cancer treatment that uses LED light and SnOx nanoflakes to precisely target cancer cells without harming healthy ones. The treatment achieved remarkable effectiveness in neutralizing colorectal and skin cancer cells, with up to 92% kill rate in just 30 minutes of exposure.
SourceUniversity of Texas at Austin·JournalACS Nano·DateOct 10, 2025
Joanna Wardwell-Ozgo, a Kennesaw State assistant professor, received a $720,000 NIH grant to investigate the hormonal control of cancer. She aims to understand how hormones affect cellular growth and development, with potential implications for disease mechanisms.
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.